Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome.

about

Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome.

Item

http://www.wikidata.org/entity/Q55440072

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome.

@en

Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome.

@nl

type

Item

label

Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome.

@en

Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome.

@nl

prefLabel

Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome.

@en

Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome.

@nl

P1476

Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome

@en

P2093

Alexander Rubin

http://www.w3.org/2001/XMLSchema#string

Gustavo Fernandez

http://www.w3.org/2001/XMLSchema#string

Jose-Nitram Aliling

http://www.w3.org/2001/XMLSchema#string

Mahek Shah

http://www.w3.org/2001/XMLSchema#string

Mary C Rodriguez Ziccardi

http://www.w3.org/2001/XMLSchema#string

Soumya Patnaik

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses

Libman-Sacks endocarditis and embolic cerebrovascular disease.

The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study.

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

[Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review].

Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features.

Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome.

P304

omy024

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1093/OMCR/OMY024

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Natee Sirinvaravong

P577

2018-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29977578

http://www.w3.org/2001/XMLSchema#string

P932

6016692

http://www.w3.org/2001/XMLSchema#string